PBI
2 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Prosthesis, Hip, Constrained, Cemented Or Uncemented, Metal/Polymer, + Additive
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 888.3310
- Medical specialty
- Orthopedic
- Flags
- Implant
- FDA definition
- For use as a component of a total hip prosthesis in primary and revision patients at high risk of dislocation due to a history of prior dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease, or intraoperative instability, and for whom all other options to constrained acetabular components have been considered.
- Adverse events (MAUDE)
- 2021: 133 · 2022: 128 · 2023: 255 · 2024: 255 · 2025: 237 · 2026: 104
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| G7® Vivacit-E® Freedom® Constrained Liner (K212512) | Zimmer, Inc. | 2022-04-28 |
| G7 ACETABULAR SYSTEM (K121874) | Biomet Manufacturing Corp | 2012-11-23 |
Track PBI automatically
Every clearance here is in the API, with alerts when new ones post.